BoxCar increases the depth and reproducibility of diabetic urinary proteome analysis
文献类型：期刊论文
| 作者 | Ye, Shu1; Zhai, Linhui2; Hu, Hao2; Tan, Minjia2 ; Du, Shichun1
|
| 刊名 | PROTEOMICS CLINICAL APPLICATIONS
 |
| 出版日期 | 2021-06-09 |
| 页码 | 12 |
| 关键词 | BoxCar DDA mass spectrometry urinary proteomics |
| ISSN号 | 1862-8346 |
| DOI | 10.1002/prca.202000092 |
| 通讯作者 | Du, Shichun(dushichun@xinhuamed.com.cn) |
| 英文摘要 | Purpose Mass spectrometry-based proteomics performs well in high throughput detection of urinary proteins. Nonetheless, protein identification depth and reproducibility remain the challenges in diabetic urinary proteome with high complexity and broad dynamic range, especially for low-abundant proteins. As a new data acquisition strategy, the BoxCar method was reported to benefit for low-abundant protein identification. Whether it is propitious to diabetic samples with high dynamic range proteomes has not been discussed yet. We aimed to apply BoxCar method to diabetic urine sample analysis, and to compare it with standard data dependent acquisition (DDA) method on protein identification in detail. Experimental Design We performed seven technical replicates analysis on two urine samples from healthy individuals and diabetic patients to evaluate protein detection of BoxCar and standard DDA methods on single sample. Further comparison of two methods was made on multiple diabetic urine samples. Results BoxCar could increase over 20% of identified proteins and performed better quantitative reproducibility than standard DDA method either in single or multiple diabetic urinary samples. BoxCar also improved the detection of low-abundant proteins. Functional enrichment analysis of normal albuminuria or microalbuminuria samples indicated that BoxCar acquired more diabetes-related biological information. Conclusions and Clinical Relevance The study demonstrates that BoxCar could enhance the depth and reproducibility in diabetic urinary proteome analysis, which provides reference for mass spectrometry approach selection in clinical urinary proteomic research. |
| WOS关键词 | DATA-INDEPENDENT ACQUISITION ; BIOMARKER DISCOVERY ; PROTEINS ; KIDNEY ; PREDICT ; DECLINE ; MS |
| 资助项目 | Natural Science Foundation of China[81600702] ; Natural Science Foundation of China[31700724] ; Natural Science Foundation of China[81872888] ; Basic research projects of Shanghai Science and Technology Commission[19JC1416300] ; Natural Science Foundation of China for Innovation Research Group[81821005] |
| WOS研究方向 | Biochemistry & Molecular Biology |
| 语种 | 英语 |
| WOS记录号 | WOS:000659180000001 |
| 出版者 | WILEY-V C H VERLAG GMBH |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/297172]  |
| 专题 | 新药研究国家重点实验室 |
| 通讯作者 | Du, Shichun |
| 作者单位 | 1.Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Endocrinol, Shanghai, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Materia Med, State Key Lab Drug Res, Shanghai, Peoples R China |
| 推荐引用方式 GB/T 7714 | Ye, Shu,Zhai, Linhui,Hu, Hao,et al. BoxCar increases the depth and reproducibility of diabetic urinary proteome analysis[J]. PROTEOMICS CLINICAL APPLICATIONS,2021:12. |
| APA | Ye, Shu,Zhai, Linhui,Hu, Hao,Tan, Minjia,&Du, Shichun.(2021).BoxCar increases the depth and reproducibility of diabetic urinary proteome analysis.PROTEOMICS CLINICAL APPLICATIONS,12. |
| MLA | Ye, Shu,et al."BoxCar increases the depth and reproducibility of diabetic urinary proteome analysis".PROTEOMICS CLINICAL APPLICATIONS (2021):12. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。